- All
- Product Name
- Product Keyword
- Product Model
- Product Summary
- Product Description
- Multi Field Search
Views: 34 Author: Site Editor Publish Time: 2022-01-05 Origin: Site
good news!
Tianlong's wisdom family adds new members! The \"hepatitis B virus (HBV) nucleic acid test kit (PCR-fluorescent probe method) \" officially developed by Tianlong Technology \"officially won the listing of the National Drug Administration (NMPA), gaining three types of medical device registration certificates . It is worth mentioning that the reagent is a national science and technological major project undertaken by Tianlong Technology \"AIDS and viral hepatitis and other major infectious disease prevention \" - \"viral hepatitis related liver cancer population warning and stove Town kit and related The strategic transformation of equipment development \"(No. 2018ZX10732-202) is therefore a priority approval.
State equipment 20213400869
Ultra-high (emphasizing the effect)
Product advantages
●Detection sensitivity:HBV detection is low to 5IU / ml, especially for low viral loading patients;
●Quantitative precision:HBV quantitative range 15 IU / mL-1.0 × 109IU / ml, can effectively guide the diagnosis and treatment;
●Convenient manipulation:Matching the automatic nucleic acid extraction system of Tianlong, HBV automation detection can be realized;
●The result is reliable:Cover the A-H 8 HBV viral subtypes, and there is an internal standard control, monitoring full.
Tianlong super highHBV automation nucleic acid detection plan
Tianlong Program includes the self-developed series of automated nucleic acid extraction, detecting equipment and reagents, super high sensitivity, magnetic drum nucleic acid extraction and fluorescent PCR technology platform, can complete the automation of HBV nucleic acids around 2 hours, let the virus Nowhere to escape!
The kit in the red frame is replaced with the correct kit.
Super-sensitiveHBVClinical significance of detection
1. Diagnosis of occult hepatitis B
2. More accurate judgment of hepatitis B treatment starting and stopping opportunities
3. Precise evaluate antiviral therapeutic effects
4. Pre-proportional drug resistance, timely adjustment of the diagnosis and treatment plan
Authoritative guide support
guide | HBV DNA detection sensitivity requirements |
China Chronic Hepatitis B Prevention Guide (2019) | TDF HBV DNA Conversion (<15 IU / mL) of the TDF alone or combined with ETV treatment group |
American Liver Disease Research Society (AASLD) 2018 | HBV DNA detection mostly use RT-PCR technology, its sensitivity is 5-10 Iu / ml |
European Liver Disease Society (EASL) 2017 | Take nucleoside drug HBV-DNA to decrease Real-time PCR method is not detected (ie below 10 IU / mL) |
Prevention, Nursing and Treatment Guide for WHO Chronic Hepatitis B Infected (2015) | HBV DNA <15 iU / ml is defined below the lower detection limit |
Asia Pacific Clinical Practice Guide (APASL) 2015 | HBV anti-virus treatment, HBV DNA is reduced to 10 iU / ml Defined as the original case recovery index |
At present, there are many HBV infected people, about 257 million people in the world infected HBV[1], China's 2020 patients reported 900,000 cases[2], Accurate nucleic acid detection is one of the important means of preventing control of hepatitis B. Tianlong Technology has always been committed to creating first-class molecular diagnosis products for human health. We are willing to contribute to viral hepatitis. \"Tianlong power \"!
Data Sources:
[1] WHO, \"Global Hepatitis Report (2017)\".
[2] China Health Jiterary Committee, \"Report of National Legal Infectious Diseases in 2020\".
